Why is Nexus Surgical falling/rising?

As of 25-Jul, Nexus Surgical and Medicare Ltd is experiencing a decline in its stock price, currently at 16.20, which reflects a decrease of 0.34 or 2.06%. The stock has fallen after two consecutive days of gains and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has underperformed significantly, with a return of -8.27%, compared to a minor decline of -0.36% in the Sensex. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 36.74% against the 5-day average. The company's long-term fundamentals appear weak, highlighted by a 9.72% CAGR growth in operating profits and a high price-to-book value of 8.4, indicating an expensive valuation despite a PEG ratio of 0.1.
In the broader market context, Nexus Surgical's performance has been notably poor, with a year-to-date return of -41.47%, contrasting sharply with the Sensex's gain of 4.25%. This underperformance is further emphasized by the stock's return of -19.68% over the past year, which is significantly worse than the BSE500's negative return of -0.19%. The finance/NBFC sector, in which Nexus Surgical operates, has also seen a decline of 2.11%, contributing to the stock's downward trend. Overall, the combination of weak investor interest, poor short-term performance compared to the benchmark, and unfavorable long-term fundamentals suggests that the stock is facing significant challenges.